-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Concentrix, Maintains $62 Price Target

Benzinga·11/20/2025 13:16:23
Listen to the news
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and maintains $62 price target.